Our information show that CK18 is consistently expressed in various epithelial cancers, Specifically adenocarcinomas. both equally loss of CK18 expression in cancers derived from CK18 favourable precursor cells and neo-expression in malignancies derived from CK18 constructive precursors are generally linked to unfavorable tumor phenotype and diseas